According to ECDC (2021), the MDR strains account for 21%, with an increasing trend for carbapenemase-producing strains (11.7%) [ 5 ].
← all excerpts
An Intra-Hospital Spread of Colistin-Resistant <i>K. pneumoniae</i> Isolates-Epidemiological, Clinical, and Genetic Analysis.
1
—
—